Related Experiment Video

Updated: Aug 13, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Association Between Melanoma and Hematologic Malignancies: Evidence From the NIH Precision Medicine Initiative

Mihir Kumar1, Amritpal Kooner2, Anchit Chauhan3

  • 1Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Pigment Cell & Melanoma Research
|August 12, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
hematologic neoplasmsimmune checkpoint inhibitorsleukemialymphomamelanoma

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...